Literature DB >> 12942894

Newborn screening for congenital adrenal hyperplasia.

Songya Pang1.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12942894     DOI: 10.3928/0090-4481-20030801-09

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN: 0090-4481            Impact factor:   1.132


× No keyword cloud information.
  6 in total

1.  The clinical and biochemical spectrum of congenital adrenal hyperplasia secondary to 21-hydroxylase deficiency.

Authors:  Tony Huynh; Ivan McGown; David Cowley; Ohn Nyunt; Gary M Leong; Mark Harris; Andrew M Cotterill
Journal:  Clin Biochem Rev       Date:  2009-05

2.  Newborn Screening for Congenital Adrenal Hyperplasia in India: What Do We Need to Watch Out for?

Authors:  R Kishore Kumar; Hari Das; Prakash Kini
Journal:  J Obstet Gynaecol India       Date:  2015-06-11

3.  Clinical and environmental influences on metabolic biomarkers collected for newborn screening.

Authors:  Kelli K Ryckman; Stanton L Berberich; Oleg A Shchelochkov; Daniel E Cook; Jeffrey C Murray
Journal:  Clin Biochem       Date:  2012-09-23       Impact factor: 3.281

Review 4.  Nonclassic adrenal hyperplasia.

Authors:  Phyllis W Speiser
Journal:  Rev Endocr Metab Disord       Date:  2009-03       Impact factor: 6.514

Review 5.  Prostate gland development and adrenal tumor in a female with congenital adrenal hyperplasia: a case report and review from radiology perspective.

Authors:  Benjamin Fang; Francis Cho; Wendy Lam
Journal:  J Radiol Case Rep       Date:  2013-12-01

6.  Assay of steroids by liquid chromatography-tandem mass spectrometry in monitoring 21-hydroxylase deficiency.

Authors:  Sandra R Dahl; Ingrid Nermoen; Ingeborg Brønstad; Eystein S Husebye; Kristian Løvås; Per M Thorsby
Journal:  Endocr Connect       Date:  2018-12       Impact factor: 3.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.